Translational immunology: Applying fundamental discoveries to human health and autoimmune diseases

JM Anaya, S Beltrán - Journal of Translational Autoimmunity, 2023 - Elsevier

Autoimmune diseases (ADs) have a common pathophysiological mechanism as a
consequence of sharing genetic and environmental factors, as well as similar clinical …

被引用次数：5 相关文章所有 4 个版本

[HTML] frontiersin.org

Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed …

JÁ Balog, Á Zvara, V Bukovinszki, LG Puskás… - Frontiers in …, 2024 - frontiersin.org

Introduction Systemic autoimmune diseases (SADs) are a significant burden on the
healthcare system. Understanding the complexity of the peripheral immunophenotype in …

被引用次数：1 相关文章所有 4 个版本

[HTML] frontiersin.org

[HTML][HTML] Global excellence in translational immunology: Europe

F Casiraghi, N Perico, G Remuzzi - Frontiers in Immunology, 2023 - frontiersin.org

The goal of biomedical research is to understand biological systems so that we can
determine the pathogenic mechanisms of disease and intervene in those processes …

Эффективность дифференцированной таргетной интерферонои иммуномодулирующей терапии, ориентированной на патологические иммунофенотипы, у …

ИВ Нестерова, ЕО Халтурина - Медицинский вестник Юга …, 2024 - medicalherald.ru

Аннотация Цель: в рамках проспективного когортного исследования оценить клинико-
иммунологическую эффективность дифференцированной таргетной интерфероно-и …

[HTML][HTML] Efficacy of differentiated targeted interferon and immunomodulatory therapy focused on pathological immunophenotypes in patients with atypical chronic …

IV Nesterova, EO Khalturina - Medical Herald of the South of …, 2024 - medicalherald.ru

Objective: In a prospective cohort study to evaluate the clinical and immunological efficacy of
differentiated targeted interferon and immunomodulatory therapies focused on identified …